BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23418377)

  • 1. Low socioeconomic status (measured by education) and outcomes in systemic sclerosis: data from the Canadian Scleroderma Research Group.
    Mansour S; Bonner A; Muangchan C; Hudson M; Baron M; Pope JE;
    J Rheumatol; 2013 Apr; 40(4):447-54. PubMed ID: 23418377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M; Bonner A; Hudson M; Baron M; Pope JE;
    Scand J Rheumatol; 2014; 43(3):217-20. PubMed ID: 24650305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
    Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
    Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis.
    Schieir O; Thombs BD; Hudson M; Boivin JF; Steele R; Bernatsky S; Hanley J; Baron M;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):409-17. PubMed ID: 20391488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.
    Chung L; Krishnan E; Chakravarty EF
    Rheumatology (Oxford); 2007 Dec; 46(12):1808-13. PubMed ID: 17986481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
    QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
    Fransen J; Popa-Diaconu D; Hesselstrand R; Carreira P; Valentini G; Beretta L; Airo P; Inanc M; Ullman S; Balbir-Gurman A; Sierakowski S; Allanore Y; Czirjak L; Riccieri V; Giacomelli R; Gabrielli A; Riemekasten G; Matucci-Cerinic M; Farge D; Hunzelmann N; Van den Hoogen FH; Vonk MC
    Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A; Bartosik I; Wuttge DM; Hesselstrand R
    Scand J Rheumatol; 2009; 38(4):295-8. PubMed ID: 19214870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Work disability in systemic sclerosis.
    Hudson M; Steele R; Lu Y; Thombs BD; ; Baron M
    J Rheumatol; 2009 Nov; 36(11):2481-6. PubMed ID: 19797513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.
    Hong P; Pope JE; Ouimet JM; Rullan E; Seibold JR
    J Rheumatol; 2004 Mar; 31(3):508-13. PubMed ID: 14994396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.